No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy / Baliakas, Panagiotis; Mattsson, Mattias; Hadzidimitriou, Anastasia; Minga, Eva; Agathangelidis, Andreas; Sutton, Lesley-Ann; Scarfo, Lydia; Davis, Zadie; Yan, Xiao-Jie; Plevova, Karla; Sandberg, Yorick; Vojdeman, Fie J; Tzenou, Tatiana; Chu, Charles C; Veronese, Silvio; Mansouri, Larry; Smedby, Karin E; Giudicelli, Véronique; Nguyen-Khac, Florence; Panagiotidis, Panagiotis; Juliusson, Gunnar; Anagnostopoulos, Achilles; Lefranc, Marie-Paule; Trentin, Livio; Catherwood, Mark; Montillo, Marco; Niemann, Carsten U; Langerak, Anton W; Pospisilova, Sarka; Stavroyianni, Niki; Chiorazzi, Nicholas; Oscier, David; Jelinek, Diane F; Shanafelt, Tait; Darzentas, Nikos; Belessi, Chrysoula; Davi, Frederic; Ghia, Paolo; Rosenquist, Richard; Stamatopoulos, Kostas. - In: HAEMATOLOGICA. - ISSN 0390-6078. - (2017), p. haematol.2017.182634. [10.3324/haematol.2017.182634]

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

Scarfo, Lydia;Ghia, Paolo;
2017-01-01

2017
Chronic Lymphocytic Leukemia; chemorefractoriness; stereotyped subsets
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/76464
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 16
social impact